
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services Inc. demonstrated a positive financial trajectory, with the Acute Care Hospital Services segment achieving a significant adjusted EBITDA margin expansion of 190 basis points to 15.8%. Additionally, the Behavioral Health Services segment reported a revenue increase of 9.3%, while the Acute Care segment's revenue grew by 12.8%, driven by both patient day growth and increased revenue per patient day. The company's outlook for 2026 remains promising due to anticipated improvements in margins stemming from easing labor and cost pressures, along with a confidence in sustaining revenue growth that outpaces costs.
Bears say
The negative outlook on Universal Health Services Inc. is primarily driven by projected volume and margin headwinds that are expected to reduce earnings by approximately 5% below estimates for FY26, with an anticipated enterprise multiple reflecting trough levels similar to those seen in 2024. Additionally, the company's revised long-term behavioral volume growth forecast now sits at 2-3%, down from prior expectations, indicating potential stagnation in a key revenue segment that is anticipated to commence a significant decline in EBITDA contributions starting in 2028. Compounding these challenges are risks associated with regulatory changes, a concentrated operational focus in the Las Vegas market, and potential pressures from a tightening clinical labor supply, all of which could adversely affect productivity and profit margins.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares